Neil M. Steven

Birmingham, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

Nivolumab With or Without Ipilimumab in Patients With Recurrent or Metastatic Merkel Cell Carcinoma: A Nonrandomized, Open-Label, International, Multicenter Phase I/II Study.

Nivolumab With or Without Ipilimumab in Patients With Recurrent or Metastatic Merkel Cell Carcinoma: A Nonrandomized, Open-Label, International, Multicenter Phase I/II Study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: January 31, 2025

Evaluation of colitis induced by immune-checkpoint inhibitors therapy in melanoma patients by an overall grading scale.

Evaluation of colitis induced by immune-checkpoint inhibitors therapy in melanoma patients by an overall grading scale.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: April 23, 2024

Head and Neck Cancer: United Kingdom National Multidisciplinary Guidelines, Sixth Edition.

Head and Neck Cancer: United Kingdom National Multidisciplinary Guidelines, Sixth Edition.

Journal: The Journal of laryngology and otology

Published: March 14, 2024

A three-arm randomised phase II study of the MEK inhibitor selumetinib alone or in combination with paclitaxel in metastatic uveal melanoma.

A three-arm randomised phase II study of the MEK inhibitor selumetinib alone or in combination with paclitaxel in metastatic uveal melanoma.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 22, 2023

Multi-omic spatial profiling reveals the unique SARS-CoV-2 lung microenvironment and collagen VI as a predictive biomarker in severe COVID-19.

Multi-omic spatial profiling reveals the unique SARS-CoV-2 lung microenvironment and collagen VI as a predictive biomarker in severe COVID-19.

Journal: The European respiratory journal

Published: October 05, 2023

A randomised phase 2 study of intermittent versus continuous dosing of dabrafenib plus trametinib in patients with BRAFV600 mutant advanced melanoma (INTERIM).

A randomised phase 2 study of intermittent versus continuous dosing of dabrafenib plus trametinib in patients with BRAFV600 mutant advanced melanoma (INTERIM).

Journal: European journal of cancer (Oxford, England : 1990)

Published: September 05, 2023

Trends in incidence, treatment and survival of Merkel cell carcinoma in England 2004-2018: a cohort study.

Trends in incidence, treatment and survival of Merkel cell carcinoma in England 2004-2018: a cohort study.

Journal: The British journal of dermatology

Published: August 08, 2022

Management of immune-related hepatitis in patients being treated with checkpoint inhibitors for metastatic melanoma, a review and case series.

Management of immune-related hepatitis in patients being treated with checkpoint inhibitors for metastatic melanoma, a review and case series.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: May 24, 2022

Eosinophilic Asthma Secondary to Adjuvant Anti-PD-1 Immune Checkpoint Inhibitor Treatment in a Melanoma Patient.

Eosinophilic Asthma Secondary to Adjuvant Anti-PD-1 Immune Checkpoint Inhibitor Treatment in a Melanoma Patient.

Journal: Case reports in oncological medicine

Published: January 06, 2022

Checkpoint Inhibition Reduces the Threshold for Drug-Specific T-Cell Priming and Increases the Incidence of Sulfasalazine Hypersensitivity.

Checkpoint Inhibition Reduces the Threshold for Drug-Specific T-Cell Priming and Increases the Incidence of Sulfasalazine Hypersensitivity.

Journal: Toxicological sciences : an official journal of the Society of Toxicology

Published: December 01, 2021

Antitumor activity of ipilimumab or BRAF ± MEK inhibition after pembrolizumab treatment in patients with advanced melanoma: analysis from KEYNOTE-006.

Antitumor activity of ipilimumab or BRAF ± MEK inhibition after pembrolizumab treatment in patients with advanced melanoma: analysis from KEYNOTE-006.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: June 29, 2021

Merkel cell carcinoma.

Merkel cell carcinoma.

Journal: Skin health and disease

Published: April 08, 2021

Showing 1-12 of 40

Last Updated: 09/26/2026